Viewing Study NCT00529451


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-22 @ 9:36 AM
Study NCT ID: NCT00529451
Status: COMPLETED
Last Update Posted: 2011-03-25
First Post: 2007-09-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertension, Aliskiren, Ramipril View